Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist.
Pineda. R R; Garcia-Galiano. D D; Roseweir. A A; Romero. M M; Sanchez-Garrido. M A MA; Ruiz-Pino. F F; Morgan. K K; Pinilla. L L; Millar. R P RP; Tena-Sempere. M M
Key Findings
- Continuous brain infusion of the kisspeptin antagonist p234 delayed vaginal opening and reduced uterine and ovarian growth in pubertal rats
- Four‑day central infusion of p234 prevented the normal pre‑ovulatory LH and FSH surges
- Systemic p234‑penetratin reduced acute LH and FSH responses to kisspeptin‑10, whether kisspeptin was given centrally or peripherally
Practical Outcomes
- The study shows that blocking kisspeptin can halt puberty and ovulation in rats, confirming its key role in female reproduction. However, there are no direct human applications, dosing guidelines, or safe protocols for biohackers, so it offers little actionable insight for personal health optimization.
Summary
Scientists gave female rats a drug that blocks kisspeptin, a hormone that triggers reproductive signals. Continuous brain infusion of this blocker delayed puberty signs and stopped the normal hormone surge that leads to ovulation. A version that can cross the blood‑brain barrier also reduced the hormone spikes caused by kisspeptin when given by injection.
Abstract
Kisspeptins (Kp) have recently emerged as master regulators of the reproductive axis and among the most potent elicitors of GnRH-gonadotropin secretion. Despite their paramount importance in reproductive physiology and their potential therapeutic implications, development of Kp antagonists has remained elusive, and only recently has the first compound with the ability to block Kp actions in vitro and in vivo, namely p234, been reported. However, previous in vivo studies all used acute central injections, whereas characterization of the effects of the antagonist after continuous or systemic administration, which poses pharmacological challenges, is still pending. We report herein a comprehensive series of analyses on the impact of continuous intracerebroventricular infusion of p234 on puberty onset and the preovulatory surge of gonadotropins in the female rat. In addition, the effects of systemic (ip) administration of a tagged p234-penetratin, with a predicted higher permeability at the blood-brain barrier, on Kp-10 induced gonadotropin secretion were evaluated. Central infusion of p234 to pubertal females delayed vaginal opening and decreased uterine and ovarian weights at the expected time of puberty, without affecting body weight. Likewise, chronic intracerebroventricular administration of p234 for 4 d prevented the preovulatory surges of LH and FSH. In addition, systemic (ip) administration of p234-penetratin significantly attenuated acute LH and FSH responses to Kp-10, either after intracerebroventricular or ip injection of Kp. Our data document the validity of p234 for antagonizing Kp actions in vivo and provide direct experimental evidence for the important role of Kp signaling in the key events of female reproduction, such as puberty onset and the preovulatory surge of gonadotropins.
Study Information
pubmed
2009
2009-12-01T00:00:00.000Z
10.1210/en.2009-0803
216
30